Intraocular lenses (IOLs) are a type of ophthalmic implants, which are used in surgeries pertaining to eyes. IOLs are synthetic lenses implanted inside the eye that substitute the focusing power of a natural lenses, which are surgically removed. These are used to treat myopia, astigmatism, or cataracts.
The global intraocular lens market generated $3,306 million in 2015, and is projected to reach $4,973 million by 2022, registering a CAGR of 7.0% during the study period. In terms of volume, the market is expected to grow at a CAGR of 7.1%. This is attributed to rise in geriatric population, increase in prevalence of cataract, and rise in initiatives taken by government to eliminate avoidable blindness. Moreover, rise in adoption of premium lens owing to their enhanced visual performance ensures reduced rates of astigmatism, thus supplementing the growth of the market. However, unfavorable reimbursement scenario for premium lens and postoperative complications such as refractive errors are expected to restrain the market growth.
The intraocular lens market is segmented based on type, material, end user, and geography. On the basis of type, the market is bifurcated into monofocal and premium intraocular lens. The premium intraocular lens is sub-segmented into toric, multifocal, accommodating, and others (blue light filtering, phakic, and aspheric intraocular lens). By material, the market is categorized into polymethylmethacrylate (PMMA), silicone, and hydrophobic acrylic. According to end user, it is divided into hospitals, ambulatory surgical centers, ophthalmology clinics, and eye research institutes. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Prominent players adopted product development and product launches & approvals as their key developmental strategies to expand their product portfolio. For instance, in July 2016, Abott Medical Optics (now acquired by Johnson & Johnson) received FDA approval for the use of Tecnis Symfony Intraocular lenses for the treatment of cataract.
KEY BENEFITS
KEY MARKET SEGMENTS
By Type
By Material
By End User
By Region
The key players profiled in this report are as follows:
Other players operating in the intraocular lens market include:
CHAPTER 1 INTRODUCTION
1.1. KEY BENEFITS
1.2. KEY MARKET SEGMENTS
1.3. RESEARCH METHODOLOGY
1.3.1. Secondary research
1.3.2. Primary research
1.3.3. Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top winning strategies
3.2.2. Top investment pockets
3.3. MARKET SHARE ANALYSIS, 2015
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.1.1. Increasing prevalence of cataract
3.4.1.2. Rise in adoption of premium intraocular lens
3.4.1.3. Increasing government initiatives
3.4.1.4. Increasing pool of geriatric population susceptible to ocular conditions
3.4.1.5. Growing number of diabetic patients
3.4.2. Restraints
3.4.2.1. Post-operative complications
3.4.2.2. Lack of coverage of premium lens
3.4.3. Opportunity
3.4.3.1. Availability of advanced technologies
3.4.3.2. Emerging nations
3.4.4. Impact analysis
3.5. PORTERS FIVE FORCES ANALYSIS
3.5.1. Bargaining power of buyers
3.5.2. Bargaining power of suppliers
3.5.3. Threat of substitutes
3.5.4. Threat of new entrants
3.5.5. Competitive rivalry
3.6. GOVERNMENT REGULATIONS
3.7. CLINICAL TRIALS
CHAPTER 4 GLOBAL INTRAOCULAR LENS MARKET, BY TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. MONOFOCAL IOLS
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. PREMIUM IOLS
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.3.3.1. Toric intraocular lenses
4.3.3.2. Market size and forecast
4.3.3.3. Multifocal intraocular lenses
4.3.3.4. Market size and forecast
4.3.3.5. Accommodating intraocular lenses
4.3.3.6. Market size and forecast
4.3.3.7. Other IOLs
4.3.3.8. Market size and forecast
4.3.3.8.1. Blue light filtering IOLs
4.3.3.8.2. Market size and forecast
4.3.3.8.3. Phakic IOLs
4.3.3.8.4. Market size and forecast
4.3.3.8.5. Aspheric IOLs
4.3.3.8.6. Market size and forecast
CHAPTER 5 GLOBAL INTRAOCULAR LENSES MARKET BY END USER
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. HOSPITALS
5.2.1. Market size and forecast
5.3. AMBULATORY SURGICAL CENTERS (ASCS)
5.3.1. Market size and forecast
5.4. OPTHALMOLOGY CLINICS
5.4.1. Market size and forecast
5.5. EYE RESEARCH INSTITUTES
5.5.1. Market size and forecast
CHAPTER 6 GLOBAL INTRAOCULAR LENS MARKET, BY MATERIAL
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. POLYMETHYLMETHACRYLATE (PMMA)
6.2.1. Market size and forecast
6.3. SILICONE
6.3.1. Market size and forecast
6.4. HYDROPHOBIC ACRYLIC
6.4.1. Market size and forecast
CHAPTER 7 GLOBAL INTRAOCULAR LENS MARKET, BY REGION
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. NORTH AMERICA
7.2.1. Key market trends
7.2.2. Growth factors and opportunities
7.2.3. Market size and forecast
7.2.4. U.S. market size and forecast
7.2.5. Canada market size and forecast
7.2.6. Mexico market size and forecast
7.3. EUROPE
7.3.1. Key market trends
7.3.2. Growth factors and opportunities
7.3.3. Market size and forecast
7.3.4. Germany market size and forecast
7.3.5. France market size and forecast
7.3.6. UK market size and forecast
7.3.7. Italy market size and forecast
7.3.8. Spain market size and forecast
7.3.9. Netherlands market size and forecast
7.3.10. Norway market size and forecast
7.3.11. Russia market size and forecast
7.3.12. Sweden market size and forecast
7.3.13. Switzerland market size and forecast
7.3.14. Rest of Europe market size and forecast
7.4. ASIA-PACIFIC
7.4.1. Key market trends
7.4.2. Growth factors and opportunities
7.4.3. Market size and forecast
7.4.4. Japan market size and forecast
7.4.5. China market size and forecast
7.4.6. India market size and forecast
7.4.7. Australia market size and forecast
7.4.8. South Korea market size and forecast
7.4.9. New Zealand market size and forecast
7.4.10. Taiwan market size and forecast
7.4.11. Thailand market size and forecast
7.4.12. Rest of Asia-Pacific market size and forecast
7.5. LAMEA
7.5.1. Key market trends
7.5.2. Growth factors and opportunities
7.5.3. Market size and forecast
7.5.4. Brazil market size and forecast
7.5.5. Saudi Arabia market size and forecast
7.5.6. South Africa market size and forecast
7.5.7. Chile market size and forecast
7.5.8. Columbia market size and forecast
7.5.9. Egypt market size and forecast
7.5.10. Iran market size and forecast
7.5.11. Israel market size and forecast
7.5.12. Turkey market size and forecast
7.5.13. Venezuela market size and forecast
7.5.14. Rest of LAMEA market size and forecast
CHAPTER 8 COMPANY PROFILES
8.1. ALCON (A NOVARTIS AG DIVISION)
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Business performance
8.1.5. Key strategic moves and developments
8.1.6. Strategy share (%)
8.2. CARL ZEISS MEDITEC AG
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Business performance
8.2.5. Key strategic moves and developments
8.2.6. Strategy share (%)
8.3. EYEKON MEDICAL, INC.
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Business performance
8.3.5. Key strategic moves and developments
8.3.6. Strategy share (%)
8.4. HUMANOPTICS AG
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Business performance
8.4.5. Key strategic moves and developments
8.4.6. Strategy share (%)
8.5. HOYA GROUP
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Business performance
8.5.5. Key strategic moves and developments
8.5.6. Strategy share (%)
8.6. JOHNSON & JOHNSON
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Business performance
8.6.5. Key strategic moves and developments
8.6.6. Strategy share (%)
8.7. LENSTEC, INC.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Business performance
8.7.5. Key strategic moves and developments
8.7.6. Strategy share (%)
8.8. RAYNER
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Business performance
8.8.5. Key strategic moves and developments
8.8.6. Strategy share (%)
8.9. STAAR SURGICAL
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Business performance
8.9.5. Key strategic moves and developments
8.9.6. Strategy share (%)
8.10. VALEANT
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Business performance
8.10.5. Key strategic moves and developments
8.10.6. Strategy share (%)
LIST OF TABLES
TABLE 1. GLOBAL VISION IMPAIRMENT BY AGE, 2010
TABLE 2. GLOBAL INTRAOCULAR LENS MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 3. GLOBAL MONOFOCAL INTRAOCULAR LENSES MARKET, BY REGION ($MILLION), 2014-2022
TABLE 4. NORTH AMERICA MONOFOCAL INTRAOCULAR LENSES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 5. EUROPE MONOFOCAL INTRAOCULAR LENSES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 6. ASIA-PACIFIC MONOFOCAL INTRAOCULAR LENSES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 7. LAMEA MONOFOCAL INTRAOCULAR LENSES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 8. GLOBAL PREMIUM INTRAOCULAR LENSES MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 9. GLOBAL PREMIUM INTRAOCULAR LENSES MARKET, BY REGION ($MILLION), 2014-2022
TABLE 10. NORTH AMERICA PREMIUM INTRAOCULAR LENSES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 11. EUROPE PREMIUM INTRAOCULAR LENSES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 12. ASIA-PACIFIC PREMIUM INTRAOCULAR LENSES MARKET, BY COUNTRY($MILLION), 2014-2022
TABLE 13. LAMEA PREMIUM INTRAOCULAR LENSES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 14. GLOBAL OTHER INTRAOCULAR LENSES MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 15. GLOBAL INTRAOCULAR LENS MARKET, BY END-USER ($MILLION), 2014-2022
TABLE 16. NORTH AMERICA INTRAOCULAR LENSES MARKET, BY END-USER ($MILLION), 2014-2022
TABLE 17. EUROPE INTRAOCULAR LENSES MARKET, BY END-USER ($MILLION), 2014-2022
TABLE 18. ASIA-PACIFIC INTRAOCULAR LENSES MARKET, BY END-USER ($MILLION), 2014-2022
TABLE 19. LAMEA INTRAOCULAR LENSES MARKET, BY END-USER ($MILLION), 2014-2022
TABLE 20. GLOBAL INTRAOCULAR LENS MARKET FOR HOSPITALS, BY REGION ($MILLION), 2014-2022
TABLE 21. GLOBAL INTRAOCULAR LENS MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION ($MILLION), 2014-2022
TABLE 22. GLOBAL INTRAOCULAR LENS MARKET FOR OPTHALMOLOGY CLINICS, BY REGION ($MILLION), 2014-2022
TABLE 23. GLOBAL INTRAOCULAR LENS MARKET FOR EYE RESEARCH INSTITUTE, BY REGION ($MILLION), 2014-2022
TABLE 24. GLOBAL INTRAOCULAR LENS MARKET, BY MATERIAL ($MILLION), 2014-2022
TABLE 25. NORTH AMERICA INTRAOCULAR LENSES MARKET, BY MATERIAL ($MILLION), 2014-2022
TABLE 26. EUROPE INTRAOCULAR LENSES MARKET, BY MATERIAL ($MILLION), 2014-2022
TABLE 27. ASIA-PACIFIC INTRAOCULAR LENSES MARKET, BY MATERIAL ($MILLION), 2014-2022
TABLE 28. LAMEA INTRAOCULAR LENSES MARKET, BY MATERIAL ($MILLION), 2014-2022
TABLE 29. GLOBAL INTRAOCULAR LENS MARKET FOR POLY METHYL METHACRYLATE, BY REGION ($MILLION), 2014-2022
TABLE 30. GLOBAL INTRAOCULAR LENS MARKET FOR SILICONE, BY REGION ($MILLION), 2014-2022
TABLE 31. GLOBAL INTRAOCULAR LENS MARKET FOR HYDROPHOBIC ACRYLIC, BY REGION ($MILLION), 2014-2022
TABLE 32. GLOBAL INTRAOCULAR LENS MARKET, BY REGION ($MILLION), 2014-2022
TABLE 33. GLOBAL INTRAOCULAR LENS MARKET, BY REGION (THOUSAND UNITS), 2014-2022
TABLE 34. NORTH AMERICA INTRAOCULAR LENSES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 35. NORTH AMERICA INTRAOCULAR LENSES MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 36. NORTH AMERICA INTRAOCULAR LENSES MARKET, BY COUNTRY (THOUSAND UNITS), 2014-2022
TABLE 37. EUROPE INTRAOCULAR LENSES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 38. EUROPE INTRAOCULAR LENSES MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 39. EUROPE INTRAOCULAR LENSES MARKET, BY COUNTRY (THOUSAND UNITS), 2014-2022
TABLE 40. ASIA-PACIFIC INTRAOCULAR LENSES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 41. ASIA-PACIFIC INTRAOCULAR LENSES MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 42. ASIA-PACIFIC INTRAOCULAR LENSES MARKET, BY COUNTRY (THOUSAND UNITS), 2014-2022
TABLE 43. LAMEA INTRAOCULAR LENSES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 44. LAMEA INTRAOCULAR LENSES MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 45. LAMEA INTRAOCULAR LENSES MARKET, BY COUNTRY (THOUSAND UNITS), 2014-2022
TABLE 46. ALCON: COMPANY SNAPSHOT
TABLE 47. ALCON: OPERATING SEGMENTS
TABLE 48. ZEISS: COMPANY SNAPSHOT
TABLE 49. ZEISS: OPERATING SEGMENTS
TABLE 50. EYEKON: COMPANY SNAPSHOT
TABLE 51. EYEKON: OPERATING SEGMENTS
TABLE 52. HUMANOPTICS: COMPANY SNAPSHOT
TABLE 53. HUMANOPTICS: OPERATING SEGMENTS
TABLE 54. HOYA: COMPANY SNAPSHOT
TABLE 55. HOYA: OPERATING SEGMENTS
TABLE 56. J&J: COMPANY SNAPSHOT
TABLE 57. J&J: OPERATING SEGMENTS
TABLE 58. LENSTEC: COMPANY SNAPSHOT
TABLE 59. LENSTEC: OPERATING SEGMENTS
TABLE 60. RAYNER: COMPANY SNAPSHOT
TABLE 61. RAYNER: OPERATING SEGMENTS
TABLE 62. STAAR: COMPANY SNAPSHOT
TABLE 63. STAAR: OPERATING SEGMENTS
TABLE 64. VALEANT: COMPANY SNAPSHOT
TABLE 65. VALEANT: OPERATING SEGMENTS
LIST OF FIGURES
FIGURE 1. INTRAOCULAR LENS MARKET, BY TYPE, 2015 VS 2022 ($MILLION)
FIGURE 2. MARKET SEGMENTATION
FIGURE 3. TOP INVESTMENT POCKETS
FIGURE 4. MARKET SHARE ANALYSIS, 2015
FIGURE 5. MAJOR CAUSES OF VISUAL IMPAIRMENT WORLDWIDE, 2010
FIGURE 6. MAJOR CAUSES OF BLINDNESS WORLDWIDE, 2010
FIGURE 7. GLOBAL IMPAIRMENT BY WHO REGION AND COUNTRY, 2010
FIGURE 8. BARGAINING POWER OF BUYERS, 2015
FIGURE 9. BARGAINING POWER OF SUPPLIERS, 2015
FIGURE 10. THREAT OF SUBSTITUTES, 2015
FIGURE 11. THREAT OF NEW ENTRANTS, 2015
FIGURE 12. COMPETITIVE RIVALRY, 2015
FIGURE 13. GEOGRAPHICAL DISTRIBUTION OF IOL CLINICAL TRIALS
FIGURE 14. IOL CLINICAL TRIALS, BY COUNTRY
FIGURE 15. IOL CLINICAL TRIALS, BY PHASE
FIGURE 16. TORIC IOL MARKET ($MILLION), 2014-2022
FIGURE 17. MULTIFOCAL IOL MARKET ($MILLION), 2014-2022
FIGURE 18. ACCOMODATING IOL MARKET ($MILLION), 2014-2022
FIGURE 19. BLUE-LIGHT FILTERING IOL MARKET ($MILLION), 2014-2022
FIGURE 20. PHAKIC IOL MARKET ($MILLION), 2014-2022
FIGURE 21. ASPHERIC IOL MARKET ($MILLION), 2014-2022
FIGURE 22. U.S. IOL MARKET ($MILLION), 2014-2022
FIGURE 23. CANADA IOL MARKET ($MILLION), 2014-2022
FIGURE 24. MEXICO IOL MARKET ($MILLION), 2014-2022
FIGURE 25. CATARACT SURGERY PROCEDURES PERFORMED IN EUROPE, BY DEMOGRAPHICS, 2012
FIGURE 26. GERMANY IOL MARKET ($MILLION), 2014-2022
FIGURE 27. FRANCE IOL MARKET ($MILLION), 2014-2022
FIGURE 28. UK IOL MARKET ($MILLION), 2014-2022
FIGURE 29. ITALY IOL MARKET ($MILLION), 2014-2022
FIGURE 30. SPAIN IOL MARKET ($MILLION), 2014-2022
FIGURE 31. NETHERLANDS IOL MARKET ($MILLION), 2014-2022
FIGURE 32. NORWAY IOL MARKET ($MILLION), 2014-2022
FIGURE 33. RUSSIA IOL MARKET ($MILLION), 2014-2022
FIGURE 34. SWEDEN IOL MARKET ($MILLION), 2014-2022
FIGURE 35. SWITZERLAND IOL MARKET ($MILLION), 2014-2022
FIGURE 36. REST OF EUROPE IOL MARKET ($MILLION), 2014-2022
FIGURE 37. LEADING CAUSES OF BLINDNESS IN JAPAN, 2013
FIGURE 38. LEADING CAUSES OF BLINDNESS IN INDIA, 2014
FIGURE 39. JAPAN IOL MARKET ($MILLION), 2014-2022
FIGURE 40. CHINA IOL MARKET ($MILLION), 2014-2022
FIGURE 41. INDIA IOL MARKET ($MILLION), 2014-2022
FIGURE 42. AUSTRALIA IOL MARKET ($MILLION), 2014-2022
FIGURE 43. SOUTH KOREA IOL MARKET ($MILLION), 2014-2022
FIGURE 44. NEW ZEALAND IOL MARKET ($MILLION), 2014-2022
FIGURE 45. TAIWAN IOL MARKET ($MILLION), 2014-2022
FIGURE 46. THAILAND IOL MARKET ($MILLION), 2014-2022
FIGURE 47. REST OF ASIA-PACIFIC IOL MARKET ($MILLION), 2014-2022
FIGURE 48. BRAZIL IOL MARKET ($MILLION), 2014-2022
FIGURE 49. SAUDI ARABIA IOL MARKET ($MILLION), 2014-2022
FIGURE 50. SOUTH AFRICA IOL MARKET ($MILLION), 2014-2022
FIGURE 51. CHILE IOL MARKET ($MILLION), 2014-2022
FIGURE 52. COLUMBIA IOL MARKET ($MILLION), 2014-2022
FIGURE 53. EGYPT IOL MARKET ($MILLION), 2014-2022
FIGURE 54. IRAN IOL MARKET ($MILLION), 2014-2022
FIGURE 55. ISRAEL IOL MARKET ($MILLION), 2014-2022
FIGURE 56. TURKEY IOL MARKET ($MILLION), 2014-2022
FIGURE 57. VENEZUELA IOL MARKET ($MILLION), 2014-2022
FIGURE 58. REST OF LAMEA IOL MARKET ($MILLION), 2014-2022
FIGURE 59. ALCON: FINANCIALS
FIGURE 60. ZEISS: FINANCIALS
FIGURE 61. EYEKON: FINANCIALS
FIGURE 62. HUMANOPTICS: FINANCIALS
FIGURE 63. HOYA: FINANCIALS
FIGURE 64. J&J: FINANCIALS
FIGURE 65. LENSTEC: FINANCIALS
FIGURE 66. RAYNER: FINANCIALS
FIGURE 67. STAAR: FINANCIALS
FIGURE 68. VALEANT: FINANCIALS
Contact us at the Consulting WP office nearest to you or submit a business inquiry online.
Subscribe to Our Newsletter
Published On : December 2019
$ 3600
Published On : December 2019
$ 3600
Published On : December 2019
$ 3600
Published On : December 2019
$ 3600
Published On : December 2019
$ 3600
Published On : December 2019
$ 3600
